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Valorisation 
“Valorisation is the process of creating value from knowledge, by making knowledge 
suitable and/or available for social and/or economic exploitation and to translate this 
knowledge into competitive products, services, processes and new commercial activi-
ties.” (adapted definition based on the National Valorisation Committee 2011:8). In 
other words, it is the important translation of scientific knowledge to social, financial 
and economical relevance.  
Economic and social burden of cSVD 
Stroke is one of the leading causes of long-term disability worldwide. In the Netherlands, 
approximately 41,000 people are yearly admitted to a hospital due to a stroke1. Further, 
the estimated number of patients who are living in the Netherlands with the conse-
quences of a stroke is nearly 310,000 people1. The medical costs of stroke are substantial, 
accounting for 2.5% of the total medical costs in the Netherlands2. Therefore, stroke 
puts a major burden on the healthcare system and society in general. It is expected that 
that these numbers will increase over the years, as the mean age of the population will 
rise and the incidence of stroke increases with age.  
Lacunar stroke accounts for 25% of all ischemic strokes and is in general caused by 
cerebral small vessel disease (cSVD), which is an umbrella term for all pathologies af-
fecting small vessels of the brain. Besides stroke, cSVD also causes cognitive impair-
ment, dementia and gait disturbances. These consequences increase the social burden of 
cSVD far beyond the negative consequences of stroke.  
The pathogenesis of cSVD is largely unknown and ways to slow down the progres-
sion of cSVD are still lacking. Comprehension of the natural course and progression of 
structural brain changes seen in cSVD, results in better understanding of both patho-
genesis and consequences of cSVD, and eventually will lead to specific treatment and 
prevention options. This thesis aids in understanding the natural disease course of cSVD 
and shows that the radiological evolution of cSVD is a highly dynamic process with 
progression, stability, regression and disappearance of cSVD lesions. These findings im-
plicate that some cSVD lesions might be reversible and imply that better vascular risk 
factor management could limit or even prevent progressive cSVD-related brain damage, 
which eventually could lead to a better clinical outcome. It is expected that total 
healthcare costs will decrease by preventing progressive cSVD-related brain damage.  
Lacunar stroke   
Lacunar stroke is generally thought to be a “minor” stroke. However, a sporadic symp-
tomatic lacunar stroke should not be seen as an isolated “minor” clinical event. A lacunar 
stroke is just one of the several clinical expressions of an underlying small vessel vascu-
lopathy with a progressive and highly dynamic course. The dynamics of cSVD seems to 
be more complex than we thought. A symptomatic lacunar infarct shows morphological 
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changes on the long term, but also shows that the surrounding brain tissue undergoes 
secondary neurodegenerative changes over time.  
Valorisation of this scientific knowledge to clinical practice needs to be done. We 
have to assess the prognostic value of these secondary white matter changes on cogni-
tion, gait and general functional outcome. However, the most important start of 
knowledge valorisation is its publication. We made the knowledge of this thesis available 
for other researchers, (healthcare) organizations and the general public in multiple, sci-
entific publications. 
Total SVD burden score 
As different MRI markers of cSVD often co-occur, it is thought that the presence of 
these MRI markers together, represents the severity of brain-related damage of cSVD. 
Earlier, our research group proposed the “total cSVD score”, which combines all indi-
vidual MRI markers of cSVD into one measure. This total cSVD burden score is easily 
applicable in clinical practice as it is a visual rating scale of conventional MRI sequences 
and does not need computer software. Further, a total cSVD burden score gives a more 
comprehensive view of the overall impact of cSVD on the brain. This thesis includes 
the first longitudinal study to determine the possible association between total cSVD 
burden and gait impairment after minor stroke. The results of this study imply that the 
total MRI burden score could be used as a neuroimaging marker of “brain frailty”, which 
identifies stroke patients at risk for (subjective) gait impairment related to cSVD, inde-
pendent of the incident stroke. Gait disturbances are common in the elderly and are 
related to functional disability, institutionalization, and death3-4.  
Last years, the interest in this compound cSVD burden score has grown and other 
research groups have adopted the concept and also studied the predictive role of total 
cSVD score on clinical outcome measures. Recent studies showed that the total cSVD 
burden could predict mortality5, unfavourable functional outcome6 and worse quality of 
life after stroke7. Therefore, the evaluation of total cSVD burden could facilitate devel-
oping individual treatment and rehabilitation strategies in patients with cSVD, which 
eventually leads to a better functional outcome. 
A similar concept for a compound cSVD progression score is needed. However, the 
development will be a challenge due to the dynamic nature of cSVD. As we showed, the 
natural evolution of cSVD is not just a simple disease progression.   
Conclusion  
This thesis helps neurologists and stroke clinicians to better understand the natural dis-
ease course of cSVD. Its seems that cSVD is not an innocent, slowly progressive disease, 
but rather a highly dynamic, accumulating, and neurodegenerative neurological disorder.  
By preventing progressive cSVD-related brain damage in the future, personalized 
treatment approaches will eventually improve clinical outcome, including gait function 
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and general functional independence. This will eventually unburden the healthcare sys-
tem and society in the future.  
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